Creatinine (Enzymatic)
Enzymatic Method, Creatinine. 510(k) K070824, from Thermofisher Scientific OY (Vantaa, FI). Product code JFY, class 2.
As of Nov 17, 2026, K070824 is an FDA 510(k) held by Thermofisher Scientific OY, substantially equivalent on Dec 3, 2007 after 252 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Dec 3, 2007
- Review time: 252 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe CREATININE (Enzymatic) is intended for quantitative in-vitro diagnostic determination of creatinine concentration in human serum, plasma (Li-heparin) or urine using T60 Clinical Chemistry Analyzers. Measurement of creatinine levels aids in the diagnosis and treatment of certain renal disease,in monitoring renal dialysis, and as a calculation basis for measuring other urine analytes.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Cobas Integra Creatinine Plus VER.2 AssayK024098 · Roche Diagnostics Corp. · Dec 19, 2002
Other JFY Clearances
The newest 510(k)s for the same product code; their median review was 185 days; see every JFY device- Qscheck UisacrK252619 · Qstag, Inc. · Feb 20, 2026
- Atellica CH Enzymatic Creatinine_3 (ECre3)K212223 · Siemens Healthcare Diagnostics, Inc. · Nov 24, 2021
- Yumizen C1200 Creatinine PAPK193649 · Horiba Abx SAS · May 10, 2021
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 26, 2007
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1225
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files